AbbVie Profile

USD 1.24  1.33%

AbbVie exotic insider transaction detected

AbbVie insider trading alert for general transaction of common stock $0.01 par value by Glenn Tilton, the corporate stakeholder, on June 24, 2018. This event was filed by Abbvie Inc with SEC on 2018-05-07. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

AbbVie Summary

AbbVie (ABBV) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 29,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 149.1 B. AbbVie conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 1.51 B outstanding shares of which 43.5 M shares are presently shorted by private and institutional investors with about 4.02 trading days to cover. AbbVie Inc. Commo currently holds about 9.47 B in cash with 8.35 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.97.
Check AbbVie Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 92.25HorizonTargetOdds Above 92.25
0.21%30 days 92.25 99.79%
Based on normal probability distribution, the odds of AbbVie to move above current price in 30 days from now is close to 99% (This AbbVie probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected AbbVie Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

AbbVie Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for AbbVie are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange. It employs 29000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
ChairmanRichard GonzalezView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address1 North Waukegan Road
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number01551152.0
IndustryPharmaceuticals And Biosciences
Contact Number847 932 7900
CurrencyUSD - US Dollar

Current Sentiment - ABBV

AbbVie Investor Sentiment
Majority of Macroaxis users are presently bullish on AbbVie. What is your sentiment towards investing in AbbVie? Are you bullish or bearish?
98% Bullish
2% Bearish


AbbVie Analyst Recommendations
Target PriceAdvice# of Analysts
AbbVie current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AbbVie Analyst Advice  


AbbVie Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.26April 27, 2017
AbbVie normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


AbbVie Corporate Directors
Frederick Waddell Independent Director
Robert Alpern Independent Director
Glenn Tilton Independent Director
Check also Trending Equities. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.